Innovators in MR Patient Care Presentation

Financial Highlights IRMD Revenue (MM) FY Revenue Non GAAP EPS 70M 60M 50M 39M 40M 30M 20M 10M OM 42M 32M 0.85 0.83 2019 Revenue by Type FY22 14 Pump 27% Warranty 4% Disp & Serv 27% 0.40 2020 2021 Monitor 41% Data as of 12/31/2022, FY23 Data guidance provided by Management on 11/3/23 53M 1.06 2022 Average over past 5 years FY23 Guidance: $65.0-65.5M $1.48-1.51 1.4 1.2 1.0 0.8 0.6 90 0.4 2023 FY22 Financial Results 77.4% Gross Margin FY22 29.3% GAAP Op. Margins FY22 $1.10 Adjusted EPS FY22 76.2% Avg Gross Margin $8.2 MM Free cash flow FY22 IRADIMED

View entire presentation